[1] 国家卫生健康委脑卒中防治工程委员会, 中华医学会神经病学分会脑血管病学组. 中国脑卒中防治指导规范(2021年版) . (2021-08-27). http://www.nhc.gov.cn/wjw/index.shtml.
[2] 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志, 2018, 51(9):666-682. doi:  10.3760/cma.j.issn.1006-7876.2018.09.004
[3] POWERS W J, RABINSTEIN A A, ACKERSON T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke association[J]. Stroke,2019,50(12):e344-e418.
[4] 王业晴, 夏玉叶, 唐颖, 等. 菸花苷对全脑缺血再灌注模型大鼠的脑保护作用[J]. 药学服务与研究, 2017, 17(2):109-113.
[5] BELAYEV L, KHOUTOROVA L, ATKINS K D, et al. Robust docosahexaenoic acid-mediated neuroprotection in a rat model of transient, focal cerebral ischemia[J]. Stroke,2009,40(9):3121-3126. doi:  10.1161/STROKEAHA.109.555979
[6] CHEN J L, YE X C, YAN T, et al. Adverse effects of bone marrow stromal cell treatment of stroke in diabetic rats[J]. Stroke,2011,42(12):3551-3558. doi:  10.1161/STROKEAHA.111.627174
[7] HASEGAWA Y, SUZUKI H, SOZEN T, et al. Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats[J]. Stroke,2010,41(2):368-374. doi:  10.1161/STROKEAHA.109.568899
[8] SUZUKI Y, CHEN F, NI Y C, et al. Microplasmin reduces ischemic brain damage and improves neurological function in a rat stroke model monitored with MRI[J]. Stroke,2004,35(10):2402-2406. doi:  10.1161/01.STR.0000140628.00927.1a
[9] DESLAND F A, AFZAL A, WARRAICH Z, et al. Manual versus automated rodent behavioral assessment: comparing efficacy and ease of bederson and garcia neurological deficit scores to an open field video-tracking system[J]. J Cent Nerv Syst Dis, 2014, 6: 7-14.

DESLAND F A, AFZAL A, WARRAICH Z, et al. Manual versus automated rodent behavioral assessment: comparing efficacy and ease of bederson and garcia neurological deficit scores to an open field video-tracking system[J]. J Cent Nerv Syst Dis, 2014, 6:7-14.
[10] PANG X M, LI T X, FENG L X, et al. Ellagic acid-induced thrombotic focal cerebral ischemic model in rats[J]. J Pharmacol Toxicol Methods,2014,69(3):217-222. doi:  10.1016/j.vascn.2014.01.001
[11] Stroke Therapy Academic Industry R. Recommendations for standards regarding preclinical neuroprotective and restorative drug development[J]. Stroke,1999,30:2752-2758. doi:  10.1161/01.STR.30.12.2752
[12] LI R P, GUO M L, ZHANG G, et al. Nicotiflorin reduces cerebral ischemic damage and upregulates endothelial nitric oxide synthase in primarily cultured rat cerebral blood vessel endothelial cells[J]. Journal of Ethnopharmacology,2006,107(1):143-150. doi:  10.1016/j.jep.2006.04.024
[13] LI R P, GUO M L, ZHANG G, et al. Neuroprotection of nicotiflorin in permanent focal cerebral ischemia and in neuronal cultures[J]. Biol Pharm Bull,2006,29(9):1868-1872. doi:  10.1248/bpb.29.1868
[14] SCHMIDT-KASTNER R, FREUND T F. Selective vulnerability of the Hippocampus in brain ischemia[J]. Neuroscience,1991,40(3):599-636. doi:  10.1016/0306-4522(91)90001-5
[15] HU H H, LI S J, WANG P, et al. An L-type calcium channel agonist, bay K8644, extends the window of intervention against ischemic neuronal injury[J]. Mol Neurobiol,2013,47(1):280-289. doi:  10.1007/s12035-012-8362-x